SCHEMBL741093

SCHEMBL741093

CC(C)(NC(=O)c1cc2c(NC(=O)c3ccccc3F)n[nH]c2s1)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.46
ABL1 P00519 2/20 0.44
BCR P11274 2/20 0.44
NPC1 O15118 7/20 0.41
RAB9A P51151 7/20 0.41
IMPDH2 P12268 1/20 0.41
SMN1; SMN2 Q16637 5/20 0.39
PLK4 O00444 1/20 0.38
PDPK1 O15530 1/20 0.38
DAPK3 O43293 1/20 0.38
DYRK3 O43781 1/20 0.38
PRKD3 O94806 1/20 0.38
MAP4K4 O95819 1/20 0.38
CHEK2 O96017 1/20 0.38
CDK1 P06493 1/20 0.38
FES P07332 1/20 0.38
RET P07949 1/20 0.38
PIM1 P11309 1/20 0.38
FGFR1 P11362 1/20 0.38
FER P16591 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1778129 0.96 AURKA (0.43) AURKAABL1BCRNPC1RAB9A
SCHEMBL2420153 0.90 NPC1 (0.42) NPC1RAB9ASMN1; SMN2PLK4PDPK1
SCHEMBL1780795 0.88 AURKA (0.45) AURKAABL1BCRTACR3RXFP1
SCHEMBL740292 0.87 AURKA (0.55) AURKAABL1BCRNPC1RAB9A
SCHEMBL1779700 0.87 AURKA (0.50) AURKAABL1BCRNPC1RAB9A
SCHEMBL742320 0.87 AURKA (0.44) AURKAABL1BCRNPC1RAB9A
SCHEMBL1778008 0.87 AURKA (0.49) AURKAABL1BCRRXFP1PPARG
SCHEMBL738866 0.86 AURKA (0.53) AURKAABL1BCRNPC1RAB9A
SCHEMBL1779328 0.86 RXFP1 (0.44) AURKAABL1BCRSMN1; SMN2TACR3
SCHEMBL1779573 0.85 AURKA (0.43) AURKAABL1BCRMAPK1TACR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed